Who can be involved:

Australia wide

  • Cutting-edge, cost-free specialist diagnostics
  • Who can be involved:
  • Male or female, aged 55 – 85 years inclusive, at the time of informed consent
  • Must be diagnosed with mild-moderate cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s disease
  • Has an identified, reliable, study partner
  • Have no serious medical conditions


The Australian Dementia Network (ADNeT) Screening and Trials initiative is creating opportunities for Australians living with Dementia to access new therapies under development by attracting major international dementia trials to Australia.

The initiative provides clinicians with cutting-edge specialist diagnostic techniques to facilitate recruitment into intervention trials across Australia.

Eligible patients undergo amyloid PET brain imaging, MRIs and comprehensive and neuropsychological assessments. Results are provided to referring clinicians to assist with diagnosis and patient management.

What is involved:

  • Involves up to 5 study visits, repeated at 2 – yearly intervals
  • Must be able to tolerate MRI and PET scans
  • Must be willing to undergo blood tests
  • Must be willing to undergo memory assessments

Additional info:

For further information please contact Mark Rodrigues, Clinical Trial Coordinator at Ph: (08) 6457 0266 or Email:

Visit ADNet